DB18571InvestigationalCell transplant therapies
DCVAC/OvCa is a therapy comprising autologous dendritic cells pulsed with killed ovarian cancer cells and matured by TLR3 ligand ex vivo. It is under investigation for the treatment of ovarian...
- Code names
- DCVAC OvCa
What you can answer from here — as of October 03, 2023
Which companies are running trials of DCVAC/OvCa, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account